Corrigendum to "Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma" [Oral Oncology 44 (2008) 464-470] (DOI:10.1016/j.oraloncology.2007.06.004);Retrospective case series of gemcitabine plus cisplatin in the treatment of recurrent and metastatic nasopharyngeal carcinoma

Oral Oncology

Volumn 44, Issue 5, 2008, Pages 464-470

  Wang, Jialei ^a   Li, Jin ^a   Hong, Xiaonan ^a   Tang, Weiyu ^a   Hu, Xichun ^a   Wang, Biyun ^a   Gu, Ye ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Chemotherapy; Cisplatin; Efficacy; Gemcitabine; Head and neck cancer; Metastatic nasopharyngeal carcinoma; Response; Toxicity

Indexed keywords

CARBOPLATIN; CISPLATIN; FLUOROURACIL; GEMCITABINE; SEROTONIN 3 ANTAGONIST;

ADOLESCENT; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANEMIA; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG ERUPTION; ETHNICITY; FEMALE; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; METASTASIS; NASOPHARYNX CARCINOMA; NEUTROPENIA; PRIORITY JOURNAL; RECURRENT CANCER; RETROSPECTIVE STUDY; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT RESPONSE; VOMITING;

EID: 42949151440     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.05.005     Document Type: Erratum

References (29)

1. M.C. Yu J.M. Yuan Epidemiology of nasopharyngeal carcinoma Semin Cancer Biol 12 2002 421 429
2. C. Her Nasopharyngeal cancer and the Southeast Asian patient Am Fam Physician 63 2001 1776 1782
3. A. Fandi M. Altun N. Azli J.P. Armand E. Cvitkovic Nasopharyngeal cancer: epidemiology, staging, and treatment Semin Oncol 21 1994 382 397
4. Y.W. Zhang S.Q. He Q.F. Chen X.X. Qiu S.L. Huan C.Q. Chen Radiation treatment of cervical metastasis in carcinoma of nasopharynx Zhonghua Zhong Liu Za Zhi 3 1981 117 122
5. S.C. Huang L.T. Lui T.C. Lynn Nasopharyngeal cancer: study III. A review of 1206 patients treated by combined modalities Int J Radiat Oncol Biol Phys 11 1985 1789 1793
6. L. Licitra J. Bernier E. Cvitkovic C. Grandi S. Spinazzé P. Bruzzi Cancer of the nasopharynx Crit Rev Oncol Hematol 45 2003 199 213
7. H. Boussen E. Cvitkovic J.L. Wendling N. Azli M. Bachouchi R. Mahjoubi Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil J Clin Oncol 9 1991 1675 1681
8. R. Choo I. Tannock Chemotherapy for recurrent or metastatic carcinoma of the nasopharynx: a review of the Princess Margaret Hospital experience Cancer 68 1991 2120 2124
9. D.A. Decker A. Drelichman M. Al-Sarraf J. Crissman M.L. Reed Chemotherapy for nasopharyngeal carcinoma: a ten-year experience Cancer 52 1983 602 605
10. K.H. Chi W.K. Chan D.L. Cooper S.H. Yen C.Z. Lin K.Y. Chen A phase II study of outpatient chemotherapy with cisplatin, 5-Fu, and leucovorin in nasopharyngeal carcinoma Cancer 73 1994 247 252
11. E. Au P.T. Ang A phase II trial of 5-Fu and cisplatin in recurrent or metastatic nasopharyngeal carcinoma Ann Oncol 5 1994 87 89
12. G.J. Peters A.M. Bergman V.W. Ruiz van Haperen G. Veerman C.M. Kuiper B.J. Braakhuis Interaction between cisplatin and gemcitabine in vitro and in vivo Semin Oncol 22 suppl 1995 S72 S79
13. K.F. Foo E.H. Tan S.S. Leong J.T. Wee T. Tan K.W. Fong Gemcitabine in metastatic nasopharyngeal carcinoma of the undifferentiated type Ann Oncol 13 2002 150 156
14. B.B. Ma I.F. Tannock G.R. Pond M.R. Edmonds L.L. Siu Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma Cancer 95 2002 2516 2523
15. R.K. Ngan H.H. Yiu W.H. Lau S. Yau F.Y. Cheung T.M. Chan Combination gemcitabine and cisplatin chemotherapy for metastatic or recurrent nasopharyngeal carcinoma: report of a phase II study Ann Oncol 13 2002 1252 1258
16. Y. Jiang Y.Q. Wei F. Luo L.Q. Zou J.Y. Liu F. Peng Gemcitabine and cisplatin in advanced nasopharyngeal carcinoma: a pilot study Cancer Invest 23 2005 123 128
17. P. Therasse S.G. Arbuck E.A. Eisenhauer J. Wanders R.S. Kaplan L. Rubinstein New guidelines to evaluate the response to treatment in solid tumors European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 92 2000 205 216
18. R. Hitt D. Castellano M. Hidalgo R. García-Carbonero M. Peña A. Brandariz Phase II trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck Ann Oncol 9 1998 1347 1349
19. S.S. Leong J. Wee M.H. Tay C.K. Toh S.B. Tan C.H. Thng Paclitaxel, carboplatin, and gemcitabine in metastatic nasopharyngeal carcinoma Cancer 103 2005 569 575
20. C.C. Wang J.Y. Chang T.W. Liu C.Y. Lin Y.C. Yu R.L. Hong Phase II study of gemcitabine plus vinorelbine in the treatment of cisplatin-resistant nasopharyngeal carcinoma Head Neck 28 2006 74 80
21. T.E. Ciuleanu G. Fountzilas E. Ciuleanu M. Plataniotis N. Todor N. Ghilezan Paclitaxel and carboplatin in relapsed or metastatic nasopharyngeal carcinoma: a multicenter phase II study J BUON 9 2 2004 161 165
22. D.T. Chua J.S. Sham G.K. Au A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma Oral Oncol 41 6 2005 589 595
23. J.H. Schiller D. Harrington C.P. Belani C. Langer A. Sandler J. Krook Comparison of four chemotherapy regimens for advanced non-small cell lung cancer N Engl J Med 346 2002 92 98
24. H. von der Maase S.W. Hansen J.T. Roberts L. Dogliotti T. Oliver M.J. Moore Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study J Clin Oncol 18 2000 3068 3077
25. A.T. Chan M.M. Hsu B.C. Goh E.P. Hui T.W. Liu M.J. Millward Multicenter, phase II study of cetuximab in combination with carboplatin in patients with recurrent or metastatic nasopharyngeal carcinoma J Clin Oncol 23 2005 3568 3576
26. J. Trigo P. Hitt P. Koralewski F. Diaz-Rubio R. Rolland N. Knecht Cetuximab monotherapy is active in patients (pts) with platinum-refractory recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN): results of a phase II study (abstract) ASCO annual meeting proceedings (post-meeting edition). J Clin Oncol 22 suppl 2004 S488
27. D. Poon B. Chowbay Y.B. Cheung S.S. Leong E.H. Tan Phase II study of irinotecan (CPT-11) as salvage therapy for advanced nasopharyngeal carcinoma Cancer 103 3 2005 576 581
28. K. Altundag S. Aksoy I. Gullu O. Altundag E. Ozyar S. Yalcin Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with cisplatin-based chemotherapy Med Oncol 21 3 2004 211 215
29. D.T. Chua J.S. Sham G.K. Au A phase II study of capecitabine in patients with recurrent and metastatic nasopharyngeal carcinoma pretreated with platinum-based chemotherapy Oral Oncol 39 4 2003 361 366